Zobrazeno 1 - 10
of 217
pro vyhledávání: '"Emilio A, Emini"'
Autor:
Anne Fiquet, Martin van Cleeff, Alejandra Gurtman, Vani Sundaraiyer, William B. Smith, William C. Gruber, Emilio A. Emini, Mohinder Sidhu, Beate Schmoele-Thoma, Matthew Davis, Robert W. Frenck, Daniel A. Scott, John Rubino
Publikováno v:
Vaccine. 34:3454-3462
Background Vaccination effectively reduces invasive disease and pneumonia caused by Streptococcus pneumoniae. However, waning antibody titers and the ability of revaccination to boost titers in older adults have been concerns. A study to describe ant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78cb0c5782bd489a5725ecf385710c54
https://doi.org/10.1016/j.vaccine.2016.04.093
https://doi.org/10.1016/j.vaccine.2016.04.093
Autor:
Emilio A. Emini, A. Krishna Prasad, Stephen P. Lockhart, Daniel A. Scott, Kathrin U. Jansen, Annaliesa S. Anderson, William C. Gruber, Jeremy A. Duke, Fikri Y. Avci, Jin-hwan Kim, Jianxin Gu, Kent Murphy, Stephen A. Kolodziej, Francesco Berti, Michelle M. Kuttel, Neil Ravenscroft, A. R. Vartak, S. J. Sucheck, Lakshmi Khandke, Jo Anne Welsch, Mark R. Alderson, Ingrid L. Scully, Kena A. Swanson, Isis Kanevsky, Mario A. Monteiro, Alexander Noll, Renee M. Laird, Brittany Pequegnat, Zuchao Ma, Lisa Bertolo, Christina DePass, Eman Omari, Pawel Gabryelski, Olena Redkyna, Yuening Jiao, Silvia Borrelli, Frederic Poly, Patricia Guerry, Christopher Jones, John P. Hennessey, Paolo Costantino, Philippe Talaga, Michel Beurret, Earl Zablackis, Carl Frasch
Autor:
Allison Thompson, Alejandra Gurtman, Vani Sundaraiyer, John Rubino, Thomas R. Jones, John J. Treanor, LM Baxter, Emilio A. Emini, William C. Gruber, Daniel A. Scott, Beate Schmoele-Thoma, Kristina A. Bryant, Robert W. Frenck
Publikováno v:
Vaccine. 33:5854-5860
Background Based on the success of vaccination with pneumococcal conjugate vaccines (PCVs) in children, recent studies have focused on PCVs in adults. Data from a randomized, double-blind study comparing the immunogenicity, tolerability, and safety o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::966abd1394f53ea75ce617d55978e16a
https://doi.org/10.1016/j.vaccine.2015.08.080
https://doi.org/10.1016/j.vaccine.2015.08.080
Autor:
As’ad E. Bhorat, Shabir A. Madhi, France Laudat, Vani Sundaraiyer, Alejandra Gurtman, Kathrin U. Jansen, Daniel A. Scott, Emilio A. Emini, William C. Gruber, Beate Schmoele-Thoma
Publikováno v:
AIDS (London, England)
Supplemental Digital Content is available in the text
Objective: Immunocompromised individuals are at an increased risk of pneumococcal disease. Vaccination is recommended as an important strategy to reduce risk of pneumococcal disease in HIV-in
Objective: Immunocompromised individuals are at an increased risk of pneumococcal disease. Vaccination is recommended as an important strategy to reduce risk of pneumococcal disease in HIV-in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc7af7d183453fc75c11c87a85a4d27a
http://europepmc.org/articles/PMC4521829
http://europepmc.org/articles/PMC4521829
Autor:
Anne Fiquet, Sami Al Hajjar, Miguel R. Abboud, Mariane de Montalembert, Alberto Tozzi, Paul T. Heath, William C. Gruber, Galila M. Mokhtar, Natasha B. Halasa, Adlette Inati, Antonio Giulio Piga, David C. Rees, Emilio A. Emini, Paul Telfer, Daniel A. Scott, Qin Jiang, Baba Inusa, Alejandra Gurtman, Jeffrey D. Lebensburger, Normeen Kaddah, Catherine Driscoll
Publikováno v:
Pediatric Blood & Cancer. 62:1427-1436
Background A large population of older children with sickle cell disease (SCD) is currently vaccinated with only 23-valent pneumococcal polysaccharide vaccine (PPSV23). In immunocompetent adults, PPSV23 vaccination reduces immune responses to subsequ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f99e258f6bf61d937ca6058d9320634c
https://doi.org/10.1002/pbc.25502
https://doi.org/10.1002/pbc.25502
Autor:
Bogusław Tetiurka, Peter C. Giardina, Ewa Toporowska-Kowalska, Krystyna Wasowska-Królikowska, William C. Gruber, Jacek Wysocki, Jerzy Brzostek, Daniel A. Scott, Denise A. Sarkozy, Henryk Szymański, Emilio A. Emini
Publikováno v:
Vaccine. 33:1719-1725
Streptococcus pneumoniae infections are a major cause of morbidity and mortality in children5 years old worldwide. To increase serotype coverage globally, a 13-valent pneumococcal conjugate vaccine (PCV13) has been developed and approved in many coun
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aef0428128a7a2cb5360005d6189aee4
https://doi.org/10.1016/j.vaccine.2015.02.005
https://doi.org/10.1016/j.vaccine.2015.02.005
Autor:
Chris Webber, Mohinder Sidhu, Emilio A. Emini, Michael Patton, Diederick E. Grobbee, Marlies A. van Houten, Wayne Drews, Scott Patterson, William C. Gruber, Marc J. M. Bonten, Anna M M van Deursen, Daniel A. Scott, Elisabeth A. M. Sanders
Publikováno v:
Clinical Infectious Diseases, 65(5), 787. Oxford University Press
Background In the randomized controlled Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA), the efficacy of the 13-valent pneumococcal conjugate vaccine (PCV13) against first episodes of vaccine-type community-acquired pneumonia in ad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::361ee0a0b31c39a7b96ba1d96dfcc68c
https://pubmed.ncbi.nlm.nih.gov/29017280
https://pubmed.ncbi.nlm.nih.gov/29017280
Autor:
Emilio A. Emini
Publikováno v:
Carbohydrate-Based Vaccines: From Concept to Clinic. :xi-xii
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::17d5a17db431bd31a1ec06423a7aece5
https://doi.org/10.1021/bk-2018-1290.pr002
https://doi.org/10.1021/bk-2018-1290.pr002
Autor:
Kathrin U. Jansen, Deepthi Jayawardene, Martin van Cleeff, Daniel A. Scott, Carmel Devlin, Lisa A. Jackson, Beate Schmoele-Thoma, Emilio A. Emini, William C. Gruber, Alejandra Gurtman
Publikováno v:
Vaccine. 31:3577-3584
Background Streptococcus pneumoniae is a major cause of morbidity and mortality among adults 50 years of age and older in the United States. Pneumococcal conjugate vaccines are efficacious against pneumococcal disease in children and may also offer a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e096aaa856e97690b9308dfb8a674320
https://doi.org/10.1016/j.vaccine.2013.04.085
https://doi.org/10.1016/j.vaccine.2013.04.085
Autor:
Alejandra Gurtman, Beate Schmoele-Thoma, Thomas R. Jones, Richard N. Greenberg, Lisa A. Jackson, Kathryn L. Rice, William C. Gruber, Emilio A. Emini, Karlis Pauksens, Daniel A. Scott
Publikováno v:
Vaccine. 31(35):3585-3593
BackgroundThe currently recommended single dose of the 23-valent pneumococcal free polysaccharide vaccine (PPSV23) for adults 65 years of age and older does not provide extended protection into older age. This reflects a significant unmet medical nee
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b909f6d7494b681023f6d0f777b230f